Status and phase
Conditions
Treatments
About
Primary Objectives:
To assess in overweight to obese T2DM patients:
Full description
Study duration is approximately 7 weeks with a 20 days treatment period.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Inclusion criteria :
Exclusion criteria:
The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
Primary purpose
Allocation
Interventional model
Masking
13 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal